Published • loading... • Updated
Ozempic Face, Blindness Claims, And Billions In Potential Damages: The GLP-1 Reckoning
Summary by wbap.com
2 Articles
2 Articles
The Dallas Express NewsReposted by 
wbap.com
wbap.comOzempic Face, Blindness Claims, And Billions In Potential Damages: The GLP-1 Reckoning
A surge in demand for GLP-1 receptor agonist drugs such as Ozempic has transformed them from treatments primarily for type 2 diabetes into popular weight-loss medications, fueling shortages, cultural trends, and now thousands of lawsuits alleging serious side effects. Novo Nordisk’s Ozempic (semaglutide) and similar drugs from Eli Lilly have seen prescriptions explode, with off-label use for weight loss driving much of the growth. As of recent r…
·Dallas, United States
Read Full ArticleCoverage Details
Total News Sources2
Leaning Left0Leaning Right2Center0Last UpdatedBias Distribution100% Right
Bias Distribution
- 100% of the sources lean Right
100% Right
R 100%
Factuality
To view factuality data please Upgrade to Premium
